期刊文献+

冠心病患者经皮冠状动脉介入治疗后支架内再狭窄复发的危险因素及预测模型构建研究

Study on Risk Factors and Development of a Predictive Model for Recurrent In-stent Restenosis in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:探索冠心病患者经皮冠状动脉介入治疗(PCI)后支架内再狭窄复发的危险因素,并初步构建支架内再狭窄复发的可视化风险预测模型。方法:收集中国医学科学院阜外医院2017年1~12月1 102例PCI后支架内再狭窄住院患者纳入分析。采用单因素Cox回归分析、LASSO回归及结合临床经验筛选支架内再狭窄复发的预测因子,多因素Cox回归分析建立预测模型。结果:中位随访1 264(1 169,1 334)d期间,111例(10.1%)患者支架内再狭窄复发。多因素Cox回归分析显示,年龄(HR=0.98,95%CI:0.96~0.99)、总胆红素(HR=0.95,95%CI:0.91~0.99)、载脂蛋白A1(HR=0.08,95%CI:0.02~0.42)、高敏C反应蛋白(HR=1.05,95%CI:1.01~1.10)和参照血管直径(HR=0.65,95%CI:0.44~0.98)是支架内再狭窄复发的危险因素,支架内再狭窄复发风险预测模型ROC曲线的AUC为0.70(95%CI:0.64~0.77)。结论:年龄、总胆红素、载脂蛋白A1和参照血管直径越小、高敏C反应蛋白水平越高,支架内再狭窄复发的风险越高;可视化的支架内再狭窄复发风险预测模型预测性能较好,但仍需进一步优化和验证。 Objectives:To explore the risk factors for recurrent in-stent restenosis(R-ISR)in patients with coronary heart disease after percutaneous coronary intervention(PCI)and to develop a risk prediction model for R-ISR using a nomogram.Methods:All patients treated for ISR at the Fuwai Hospital,Chinese Academy of Medical Sciences from January to December 2017 were eligible for this study.A total of 1102 ISR patients were included for analysis.Based on the recurrence of ISR after PCI,patients were divided into R-ISR group and non-R-ISR group.Univariate Cox regression analyses,LASSO regression analyses,and the combination of clinical experience were used to select predictors of R-ISR.A multivariate Cox regression model was used to analyze the independent risk factors of R-ISR and to develop a risk prediction model.Results:The median follow-up duration for participants was 1264(1169,1334)days,the incidence rate of R-ISR after PCI was 10.1%.Multivariate Cox regression analysis showed that age(HR=0.98,95%CI:0.96-0.99),total bilirubin(HR=0.95,95%CI:0.91-0.99),apolipoprotein A1(HR=0.08,95%CI:0.02-0.42),high-sensitivity C-reactive protein(HR=1.05,95%CI:1.01-1.10),and reference vessel diameter(HR=0.65,95%CI:0.44-0.98)were independent determinants of R-ISR.Accordingly,the R-ISR risk prediction model was developed with a nomogram,the AUC of this model to predicto R-ISR was 0.70(95%CI:0.64-0.77).Conclusions:Coronary heart disease patients with younger age,lower levels of total bilirubin and apolipoprotein A1,smaller vessel diameter,and higher levels of high-sensitivity C-reactive protein are at higher risk of R-ISR.The developed visual risk prediction model for R-ISR shows promising predictive performance but still requires further optimization and validation.
作者 朱晨玉江 吕湛 朱法胜 王勇 黄永培 王天杰 杨伟宪 ZHU Chenyujiang;LYU Zhan;ZHU Fasheng;WANG Yong;HUANG Yongpei;WANG Tianjie;YANG Weixian(Department of Clinical Medicine,North Sichuan Medical College,Nanchong 637000,China;Department of Cardiology,National Center for Cardiovascular Diseases and Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China;Department of Cardiology,Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,China;Department of Cardiology,Shifang People's Hospital,Shifang 618400,China)
出处 《中国循环杂志》 CSCD 北大核心 2024年第5期456-463,共8页 Chinese Circulation Journal
关键词 冠心病 经皮冠状动脉介入治疗 复发性支架内再狭窄 危险因素 预测模型 coronary heart disease percutaneous coronary intervention recurrent in-stent restenosis risk factor prediction model
  • 相关文献

参考文献9

二级参考文献131

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:60
  • 2赵文华,张坚,由悦,满青青,李红,王春荣,翟屹,李莹,金水高,杨晓光.中国18岁及以上人群血脂异常流行特点研究[J].中华预防医学杂志,2005,39(5):306-310. 被引量:524
  • 3姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 4徐昌盛,刘文革,叶伟.肠系膜动脉栓塞和血栓形成荟萃分析[J].中华胃肠外科杂志,2007,10(6):524-527. 被引量:34
  • 5Baranano DE, Rao M, Ferris CD,et al. Biliverdin reductase: a major physiologic cytoprotectant[ J]. Proc Natl Acad Sci U S A, 2002,99 ( 25 ) : 16093-16098.
  • 6Hunt SC, Kronenberg F, Eckfeldt JH, et al. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study [J ]. Atherosclerosis ,2001,154 ( 3 ) :747-754.
  • 7Lin JP, O'Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1 * 28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study [ J]. Circulation,2006,114 (14) :1476-1481.
  • 8Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease[ J]. Clin Chem,1994,40( 1 ) :18-23.
  • 9Madhavan M, Wattigney WA, Srinivasan SR, et al. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults [ J ]. Atherosclerosis, 1997,131 ( 1 ) : 107-113.
  • 10Turfan M, Duran M, Poyraz F,et al. Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease [ J]. Coron Artery Dis,2013,24 ( 1 ) : 29-32. DOI: 10. 1097/MCA. 0b013e32835b0c13.

共引文献664

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部